Literature DB >> 17195706

Mycetoma in children: experience with 15 cases.

Alexandro Bonifaz1, Guadalupe Ibarra, Amado Saúl, Vanessa Paredes-Solis, Eugenio Carrasco-Gerard, Leonel Fierro-Arias.   

Abstract

BACKGROUND: Mycetoma is a chronic infection caused by aerobic actinomycetes and filamentous fungi. It is an occupational disease frequent in tropical countries and is uncommon in children.
METHODS: A retrospective (25 years) report of mycetomas was conducted in children less than 15 years of age. Each of the cases was studied clinically and proven with microbiologic tests: direct examinations (to identify and classify the grains), cultures and identification based on morphology and biochemical tests. The therapeutic experience of the cases was also reviewed.
RESULTS: In a 25-year period, a total of 334 mycetomas were seen at our institution, 15 of which (4.5%) were in patients 15 years of age and younger (mean age: 11.2 years, age range: 6-15 years). Twelve cases were males and 3 females. The main clinical location was the foot in 10 of 15 (66.6%). Etiologies included 13 actinomycetomas and 2 eumycetomas. Etiologic agents were Nocardia brasiliensis in 12 cases, Nocardia asteroides in one and Madurella mycetomatis in 2. Eleven of the13 cases of actinomycetomas treated with trimethoprim-sulfamethoxazole plus diaminodiphenylsulfone were cured. The 2 failures were successfully treated with amoxicillin/clavulanate. One of the eumycetomas was cured with itraconazole therapy, whereas the other failed various treatments eventuating in surgical amputation.
CONCLUSIONS: Mycetomas are exceptional in children; in our setting, actinomycetomas are more frequent than eumycetomas. The clinical and microbiologic diagnosis is simple. Overall, treatment response is better for actinomycetomas than for eumycetomas.

Entities:  

Mesh:

Year:  2007        PMID: 17195706     DOI: 10.1097/01.inf.0000247108.86199.64

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Identification of Differentially Expressed Genes in Nocardia brasiliensis Induced by Progesterone and Dihydrotestosterone Using Differential Display PCR.

Authors:  Claudia C Paredes-Amaya; Patricia Manzano-Gayosso; Francisca Hernández-Hernández
Journal:  Curr Microbiol       Date:  2022-10-06       Impact factor: 2.343

2.  Actinomycetoma in arm disseminated to lung with grains of Nocardia brasiliensis with peripheral filaments.

Authors:  Bertha Muñoz-Hernández; María Cecilia Noyola; Gabriel Palma-Cortés; Dora Patricia Rosete; Miguel Angel Galván; María Eugenia Manjarrez
Journal:  Mycopathologia       Date:  2009-02-24       Impact factor: 2.574

Review 3.  Actinomycetoma-the welsh regimen in a rural Indian scenario.

Authors:  Saumya Mathews; Raviraj Jadhav; Ali Reza; Tanweer Karim
Journal:  Indian J Surg       Date:  2012-05-01       Impact factor: 0.656

4.  Actinomycetes mycetoma.

Authors:  Sumati Hogade; S C Metgud
Journal:  J Lab Physicians       Date:  2011-01

5.  Mycetoma: experience of 482 cases in a single center in Mexico.

Authors:  Alexandro Bonifaz; Andrés Tirado-Sánchez; Luz Calderón; Amado Saúl; Javier Araiza; Marco Hernández; Gloria M González; Rosa María Ponce
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

6.  A Teenage Girl With Painful Walking and a Left Foot Mass.

Authors:  Shipra Gupta; Amrit Misra; Mahdi Alsaleem; Nahed Abdel-Haq
Journal:  Glob Pediatr Health       Date:  2015-09-15

7.  Efficacy of DA-7218, a new oxazolidinone prodrug, in the treatment of experimental actinomycetoma produced by Nocardia brasiliensis.

Authors:  Nelly Alejandra Espinoza-González; Oliverio Welsh; Noemi Waksman de Torres; Norma Cavazos-Rocha; Jorge Ocampo-Candiani; Salvador Said-Fernandez; Gerardo Lozano-Garza; Sung-Hak Choi; Lucio Vera-Cabrera
Journal:  Molecules       Date:  2008-01-11       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.